Attachment and Prognostic Factor: the Implicit Approach
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Questionnaires.
- Who it may be relevant to
- Registry conditions: Dependence Addictive. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Place of Attachment as a Post-weaning Prognostic Factor: Interest of the Implicit Approach
Overview
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence. 5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator.
Interventions
- Behavioral Questionnaires
5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator
Primary outcome measures
- Implicit attachment and onsumption [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- Patients between 18 and 65 years old
- Patients with a use-related disorder as defined by DSM5
- Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
- Having expressed non-opposition to participating in the study after receiving written information.
Exclusion criteria
- Person who cannot read or write
- Simultaneous participation in a therapeutic trial involving oxytocin
- Patients protected by law
- Patients who do not have French as their native language
- Patients who, in the opinion of the investigator, are unable to complete the questionnaires
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT04954027 · 2021-A00432-39